During the past decade, Hospital de Antequera conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Antequera" #1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Antequera" are "Acute Coronary Syndrome" (1 trials), "COVID-19" (1 trials), "Maternal Immunization" (1 trials), "Respiratory Tract Infection" (1 trials) and "SARS-CoV-2 Infection" (1 trials). Many other conditions were trialed in "Hospital de Antequera" in a lesser frequency.

Most popular intervention types in "Hospital de Antequera" are "Biological" (3 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BNT162b2" (1 trials), "BNT162b2 20mcg" (1 trials), "BNT162b2 30mcg" (1 trials) and "Biological/Vaccine: BNT162b2 10mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Antequera" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital de Antequera". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital de Antequera, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Antequera, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".